Alectinib 150mg Capsule – Imported | Lucius Pharmaceuticals

Product Overview

Alectinib 150mg Capsule – Imported is a targeted anticancer medicine containing alectinib, a kinase inhibitor used in the treatment of certain types of non-small cell lung cancer (NSCLC) associated with anaplastic lymphoma kinase (ALK) alterations. It works by blocking abnormal ALK signalling that can promote cancer cell growth.

Alectinib is prescribed following appropriate diagnostic testing to determine whether a patient’s cancer is suitable for this targeted treatment. This imported product is listed with Lucius Pharmaceuticals as the manufacturer and comes in a pack size of 56 capsules. Please confirm the manufacturer’s details and product packaging before purchase.

Key Product Information

• Product Name: Alectinib 150mg Capsule
• Generic Name: Alectinib
• Strength: 150mg
• Dosage Form: Capsule
• Manufacturer: Lucius Pharmaceuticals
• Pack Size: 56 Capsules
• Product Type: Imported medicine
• Therapeutic Category: Targeted anticancer medicine
• Primary Use: Treatment of eligible patients with ALK-positive non-small cell lung cancer
• Availability: Contact MedicineWalyDost.com to confirm current stock and price in Pakistan.

Uses of Alectinib 150mg Capsules

Alectinib is used under specialist supervision for selected patients with ALK-positive non-small cell lung cancer. Depending on the approved indication and individual treatment plan, it may be prescribed:

• To treat ALK-positive NSCLC that has spread to other parts of the body.
• As adjuvant treatment after surgical removal of eligible ALK-positive lung cancer.
• As part of a targeted treatment plan based on the patient’s cancer diagnosis and molecular testing results.

Alectinib is not intended for every type of lung cancer. A specialist must confirm that the patient’s cancer has the relevant ALK alteration.

How Does Alectinib Work?

Alectinib inhibits the abnormal anaplastic lymphoma kinase (ALK) protein involved in the growth and survival of certain cancer cells. By blocking this signalling pathway, it can help slow or stop the growth of cancer cells in eligible patients.

The medicine is a targeted therapy rather than a conventional chemotherapy drug. Treatment response varies between individuals and requires regular assessment by an oncology team.

Dosage and How to Take Alectinib 150mg

Alectinib must be taken exactly as prescribed by an oncologist. The appropriate dose and treatment duration depend on the approved indication, the patient’s health, treatment response, and any adverse reactions.

• Take the capsules with food, as directed by the prescribing specialist.
• Swallow the capsules according to the medicine’s instructions.
• Do not change the dose or stop treatment without consulting your oncologist.
• If a dose is missed or vomiting occurs after a dose, follow the product leaflet or contact your healthcare professional for instructions.
• Do not take extra capsules to compensate for a missed dose.

The established adult dose for the reference medicine Alecensa is 600mg twice daily with food, but the appropriate regimen must be confirmed by the treating oncologist and the specific product’s prescribing information. The 150mg strength does not mean that every patient should take a particular number of capsules without medical guidance.

Possible Side Effects

Alectinib may cause side effects, and some require prompt medical assessment.

Common or clinically important side effects can include:

• Tiredness or fatigue
• Constipation
• Muscle pain or tenderness
• Swelling of the hands, feet, or ankles
• Skin rash
• Cough
• Abnormal liver function tests
• Changes in heart rate
• Muscle enzyme abnormalities

Serious Side Effects

Seek urgent medical attention if you experience difficulty breathing, new or worsening cough, yellowing of the skin or eyes, dark urine, severe muscle pain or weakness, fainting, or other severe or unusual symptoms.

Alectinib can cause liver problems, lung inflammation, slow heart rate, muscle injury, and other serious complications. Regular medical monitoring is essential throughout treatment.

Precautions and Warnings

Before starting Alectinib 150mg Capsules, tell your doctor about all medical conditions and medicines you use.

• Liver health: Liver function tests are required before and during treatment.
• Lung symptoms: Report new or worsening breathing difficulties or cough immediately.
• Heart rate: Inform your doctor if you experience dizziness, fainting, or an unusually slow heartbeat.
• Muscle problems: Report unexplained muscle pain, tenderness, or weakness.
• Pregnancy: Alectinib may harm an unborn baby. Discuss pregnancy prevention and contraception with your specialist.
• Breastfeeding: Breastfeeding is not recommended during treatment; discuss the appropriate period after treatment with your doctor.
• Other medicines: Tell your healthcare team about all prescription medicines, over-the-counter products, vitamins, and herbal supplements.

Drug Interactions

Alectinib may interact with other medicines or treatments. Inform your oncologist about your complete medication list, including medicines that affect heart rate, liver function, or other drug-metabolising pathways.

Never start, stop, or change another medicine during cancer treatment without professional advice.

Who Should Use Alectinib?

Alectinib may be appropriate for patients whose non-small cell lung cancer has been confirmed to have an ALK alteration and who meet the relevant treatment criteria.

It is not suitable for self-medication or for use without specialist assessment. The prescribing team should review diagnostic results, medical history, other medicines, and monitoring requirements before treatment begins.

Storage Instructions

• Store the medicine according to the manufacturer’s packaging and leaflet.
• Keep capsules in their original packaging where appropriate.
• Protect the medicine from unsuitable temperature, moisture, and direct sunlight.
• Keep out of reach of children.
• Do not use capsules after the expiry date or if the packaging appears damaged.

Why Choose MedicineWalyDost.com?

MedicineWalyDost.com helps customers enquire about imported medicines and specialist pharmaceutical products in Pakistan. For Alectinib 150mg Capsules, customers can contact the team to confirm:

• Current availability and price
• Manufacturer and packaging details
• Pack size and product authenticity documentation
• Prescription requirements
• Delivery options and service availability

As Alectinib is a specialist anticancer medicine, a valid prescription and appropriate professional supervision are essential.

Frequently Asked Questions (FAQs)

1. What is Alectinib 150mg Capsule used for?

Alectinib is a targeted anticancer medicine used for certain patients with ALK-positive non-small cell lung cancer, including eligible patients after surgery and patients with advanced disease.

2. Who manufactures Alectinib 150mg Capsules listed here?

The product details provided for this listing identify Lucius Pharmaceuticals as the manufacturer. Confirm the actual manufacturer and packaging on the supplied product before purchase.

3. What is the pack size of Alectinib 150mg Capsules?

The stated pack size is 56 capsules.

4. What is the price of Alectinib 150mg in Pakistan?

The current price may vary depending on availability, import status, and supplier. Contact MedicineWalyDost.com for the latest price and stock confirmation.

5. Can I take Alectinib without a prescription?

No. Alectinib should only be used under the supervision of a qualified oncology specialist.

6. What monitoring is required during treatment?

Monitoring may include liver function tests, heart rate assessment, muscle enzyme tests, and evaluation of any breathing symptoms or other adverse reactions.

Buy Alectinib 150mg Capsule – Imported in Pakistan

Looking for Alectinib 150mg Capsules (56 Capsules)? Contact MedicineWalyDost.com to confirm current availability, pricing, manufacturer details, prescription requirements, and delivery options in Pakistan.

Choose informed purchasing and professional guidance when enquiring about specialist anticancer medicines.